@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WVZ61GT7-0
  skos:prefLabel "tendances (Qualificatif)"@fr, "trends (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XN813BSL-3
  skos:prefLabel "enseignement et éducation (Qualificatif)"@fr, "education (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-PPKJKFKK-V
  skos:prefLabel "ethics (Qualifier)"@en, "éthique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WJSMRGQV-L
  skos:prefLabel "statistiques et données numériques (Qualificatif)"@fr, "statistics & numerical data (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q0JKZ84V-W
  dc:created "1993-02-16"^^xsd:date ;
  skos:altLabel "Pharmaco-épidémiologie"@fr, "Epidemiology, Pharmaceutical"@en, "Épidémiologie pharmaceutique"@fr, "Épidémiologie pharmacologique"@fr, "Pharmaceutical Epidemiology"@en ;
  a skos:Concept, mesh:Descriptor ;
  mesh:allowableQualifier jvr:-GX844VQL-G, jvr:-R3QWLHRG-V, jvr:-W6SQV79N-S, jvr:-CB30NGKB-3, jvr:-SBNWSM1T-R, jvr:-PQ3722L4-D, jvr:-WVZ61GT7-0, jvr:-MPGVB7LK-P, jvr:-PPKJKFKK-V, jvr:-WJSMRGQV-L, jvr:-K3JH4VF9-N, jvr:-XN813BSL-3 ;
  skos:broader jvr:-QG9TGF3D-Q, jvr:-GWXB2V25-Q ;
  skos:prefLabel "Pharmacoépidémiologie"@fr, "Pharmacoepidemiology"@en ;
  dc:established "1994-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D017891> ;
  skos:inScheme jvr: ;
  skos:definition "The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))"@en ;
  dc:modified "2009-07-06"^^xsd:date .

jvr:-GX844VQL-G
  skos:prefLabel "instrumentation (Qualifier)"@en, "instrumentation (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-K3JH4VF9-N
  skos:prefLabel "methods (Qualifier)"@en, "méthodes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-PQ3722L4-D
  skos:prefLabel "legislation & jurisprudence (Qualifier)"@en, "législation et jurisprudence (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-MPGVB7LK-P
  skos:prefLabel "organization & administration (Qualifier)"@en, "organisation et administration (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QG9TGF3D-Q
  skos:prefLabel "Épidémiologie"@fr, "Epidemiology"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-Q0JKZ84V-W .

jvr:-GWXB2V25-Q
  skos:prefLabel "Pharmacologie"@fr, "Pharmacology"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-Q0JKZ84V-W .